Description

REACTINE PLUS TAB

Indications

REACTINE PLUS TAB is primarily indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. These symptoms may include sneezing, runny or itchy nose, and itchy or watery eyes. Additionally, REACTINE PLUS TAB may be utilized in the management of chronic urticaria (hives), providing relief from itching and the formation of hives. The formulation combines an antihistamine with a decongestant, addressing both allergic symptoms and nasal congestion effectively.

Mechanism of Action

REACTINE PLUS TAB contains two active ingredients: cetirizine and pseudoephedrine. Cetirizine is a selective antagonist of peripheral H1 receptors, which inhibits the action of histamine, a substance in the body that causes allergic symptoms. By blocking histamine receptors, cetirizine reduces symptoms such as sneezing, itching, and runny nose.

Pseudoephedrine, on the other hand, is a sympathomimetic amine that acts as a decongestant. It works by stimulating alpha-adrenergic receptors in the nasal mucosa, leading to vasoconstriction and a subsequent reduction in nasal congestion. The combination of these two mechanisms provides comprehensive relief from allergy symptoms and nasal congestion.

Pharmacological Properties

Cetirizine is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1 hour. It has a long half-life of approximately 8 hours, allowing for once-daily dosing. Cetirizine is primarily metabolized in the liver and excreted in urine, with around 70% of the dose eliminated unchanged.

Pseudoephedrine also exhibits rapid absorption, with peak plasma concentrations reached within 1-2 hours. Its half-life ranges from 5 to 8 hours, and it is primarily eliminated through renal excretion. The pharmacokinetics of both components support their efficacy in providing sustained relief from allergic symptoms and nasal congestion.

Contraindications

REACTINE PLUS TAB is contraindicated in individuals who have a known hypersensitivity to cetirizine, pseudoephedrine, or any other components of the formulation. It should not be used in patients with severe hypertension or severe coronary artery disease due to the vasoconstrictive properties of pseudoephedrine. Additionally, it is contraindicated in individuals taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing such treatment, as this may lead to hypertensive crises.

Side Effects

Common side effects associated with REACTINE PLUS TAB include drowsiness, dry mouth, dizziness, and fatigue. While cetirizine is less sedating than first-generation antihistamines, some individuals may still experience drowsiness. Pseudoephedrine can cause insomnia, nervousness, and increased heart rate. Serious side effects are rare but may include allergic reactions, such as rash, itching, or difficulty breathing. Patients should be advised to seek medical attention if they experience any severe or persistent side effects.

Dosage and Administration

The recommended dosage for adults and children aged 12 years and older is one tablet (containing 10 mg of cetirizine and 120 mg of pseudoephedrine) taken once daily. For children aged 6 to 11 years, a lower dosage may be recommended, and it is essential to consult a healthcare provider for appropriate dosing. The tablet should be taken with water and can be taken with or without food. Patients should adhere strictly to the recommended dosage to minimize the risk of side effects and ensure optimal therapeutic outcomes.

Interactions

REACTINE PLUS TAB may interact with other medications, potentially altering their effects or increasing the risk of side effects. Co-administration with other central nervous system depressants, such as alcohol, sedatives, or tranquilizers, may enhance sedation. Caution should be exercised when using REACTINE PLUS TAB in conjunction with medications that may raise blood pressure, as pseudoephedrine can exacerbate hypertension. Patients should inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Patients with pre-existing medical conditions, such as hypertension, cardiovascular disease, or renal impairment, should use REACTINE PLUS TAB with caution. It is advisable to monitor blood pressure regularly in patients with hypertension. Additionally, individuals with a history of seizures or epilepsy should consult a healthcare provider before using this medication, as pseudoephedrine may lower the seizure threshold. Pregnant or breastfeeding women should also seek medical advice before using REACTINE PLUS TAB, as the safety of the combination in these populations has not been fully established.

Clinical Studies

Clinical studies have demonstrated the efficacy of REACTINE PLUS TAB in relieving symptoms of allergic rhinitis and chronic urticaria. In randomized controlled trials, patients reported significant improvements in nasal congestion, sneezing, and itching compared to placebo. The combination of cetirizine and pseudoephedrine has been shown to provide faster and more comprehensive relief than either component alone. The safety profile of REACTINE PLUS TAB has also been evaluated, with most adverse effects being mild and transient.

Conclusion

REACTINE PLUS TAB is an effective medication for managing symptoms of allergic rhinitis and chronic urticaria. Its dual-action formulation addresses both allergy symptoms and nasal congestion, making it a convenient option for patients seeking relief. While generally well-tolerated, it is essential for patients to be aware of potential side effects, contraindications, and interactions with other medications. As with any medication, it is recommended to use REACTINE PLUS TAB under the guidance of a healthcare professional to ensure safe and effective treatment.